Table: Nippon Shinyaku -9-MTH group results (IFRS)
Feb 7 (Reuters)-
Nippon Shinyaku Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Dec 31, 2024 Dec 31, 2023 Mar 31, 2025
LATEST YEAR-AGO COMPANY
RESULTS RESULT FORECAST
Sales 121.32 112.73 160.00
(+7.6 pct) (+2.6 pct) (+7.9 pct)
Operating 32.75 30.45 36.00
(+7.6 pct) (+8.8 pct) (+8.1 pct)
Pretax 33.44 30.97 36.60
(+8.0 pct) (+9.0 pct) (+8.9 pct)
Net 28.55 24.00 31.50
(+19.0 pct) (+5.9 pct) (+21.9 pct)
EPS Basic 423.93 yen 356.37 yen 467.51 yen
EPS Diluted 423.84 yen
Ann Div 124.00 yen 124.00 yen
-Q2 Div 62.00 yen 62.00 yen
-Q4 Div 62.00 yen 62.00 yen
NOTE - Nippon Shinyaku Co Ltd.
(Figures are reported based on international accounting rules (IFRS).)
If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half
dividend and Q4 to the second-half dividend announced before a new corporate law in
2006 allowed companies to pay and report dividends on a quarterly basis.
*Net - represents Net profit attributable to owners of the parent company.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4516.T
Recent news on Nippon Shinyaku
See all newsTable: Nippon Shinyaku -Q1 group results (IFRS)
Brief: Elixirgen Therapeutics And Nippon Shinyaku Enter Into An Option Agreement For The Development And Commercialization Of Exg-7001 For Duchenne Muscular Dystrophy
Table: Nippon Shinyaku -2025/26 group results (IFRS)
Table: Nippon Shinyaku -2025/26 parent results
Table: Nippon Shinyaku -9-MTH group results (IFRS)